[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported multiple transactions on 09/17/2025 under a Rule 10b5-1 plan. He purchased 20,000 shares via option exercises at a stated exercise price of $10.178 per share (reported as two non-qualified option exercises of 10,000 shares each) and sold 20,000 shares in Rule 10b5-1 plan transactions at a weighted average price of $42.04 per share (sales occurred across prices ranging from $42.00 to $42.19 and $42.00 to $42.18 as disclosed). Following the reported non-derivative transactions, his direct beneficial ownership figures listed are 94,328 shares and 84,328 shares on the lines reported.

Table II shows multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including currently exercisable options and several tranches that vest over future years, totaling significant option-based potential ownership.

Insights

Financial Analyst

TL;DR: Insider exercised low-strike options and sold shares through a 10b5-1 plan; transactions appear routine and not an unusual market signal.

The filing documents option exercises at a $10.178 strike and concurrent sales under a 10b5-1 plan at a weighted average of $42.04, indicating the reporting person monetized a portion of equity while retaining meaningful direct and derivative holdings. The mix of exercises and planned sales is consistent with liquidity-taking rather than an emergent negative view of company prospects. Outstanding option tranches with multi-year vesting preserve future upside sensitivity to the share price.

Corporate Governance Expert

TL;DR: Transactions were disclosed and executed under a written 10b5-1 plan; filings include appropriate vesting and exercisability details.

The Form 4 indicates compliance with Rule 10b5-1 for sales, and provides vesting schedules and exercisability statements for multiple option grants. The reporting includes weighted-average sale price ranges and an undertaking to provide additional per-price breakdowns on request, which supports transparency. No prohibited insider trading indicators or amendments are shown in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

van Es Charles

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Sales Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		M		10,000	A	$10.178	94,328	D
Common Stock	09/17/2025		S(1)		10,000	D	$42.04(2)	84,328	D
Common Stock	09/17/2025		M		10,000	A	$10.178	94,328	D
Common Stock	09/17/2025		S(1)		10,000	D	$42.04(3)	84,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178	09/17/2025		M			10,000	(4)	02/10/2030	Common Stock	10,000	$0.0	83,750	D
Non-Qualified Stock Option (right to buy)	$10.178	09/17/2025		M			10,000	(4)	02/10/2030	Common Stock	10,000	$0.0	73,750	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	58,043		58,043	D
Non-Qualified Stock Option (right to buy)	$15.36							(7)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(10)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.18, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in three equal annual installments beginning on August 15, 2025.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Charles Van Es	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did COCO insider Charles van Es report on Form 4?

He reported option exercises and share sales on 09/17/2025: exercises converting 20,000 option shares at a $10.178 strike and sales of 20,000 shares under a Rule 10b5-1 plan at a weighted average price of $42.04.

Were the share sales by the COCO insider part of a 10b5-1 plan?

Yes. The filing indicates the sales were effected pursuant to a Rule 10b5-1 trading plan and discloses price ranges and an offer to provide per-price breakdowns on request.

How many option shares does the reporting person have that are currently exercisable?

The filing lists multiple exercisable options, including two fully vested options of 10,000 shares each and additional vested tranches (e.g., 27,300 shares) as specified in Table II.

What price were the sold shares in the Form 4 transactions?

Sales were at a weighted average price of $42.04 per share, with individual sale prices reported in ranges from $42.00 to $42.19 and $42.00 to $42.18.

Does the Form 4 indicate any non-compliance or amendments?

No amendments or compliance issues are indicated in this filing. The form includes the reporting attorney-in-fact signature and explanatory footnotes consistent with disclosure requirements.